GENERAL COMMENTS
This is a well-designed and timely systematic review protocol. Early sedation depth is appropriate for such review and has been associated with significant, clinically relevant patient outcomes. No prior systematic review has been performed on this topic to my knowledge. The introduction, methods, and discussion are clear and concise. The inclusion of grey literature is appropriate for this research given the relative lack of published data as long as these studies are clearly identified in the manuscript if included. 
Thank you for asking to review the protocol for the planned systematic review. The protocol and plan adheres to standard guidelines and methodology for syst review and MA. I suggest clarifying the method by which RCTs vs Non-RCTs will be assessed.
In addition the heterogeneity level may be dictated by the point estimate as well as the I test.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Reviewer Name: Christopher G. Hughes, MD Institution and Country: Vanderbilt University Medical Center, USA Please state any competing interests: None declared 1. This is a well-designed and timely systematic review protocol. Early sedation depth is appropriate for such review and has been associated with significant, clinically relevant patient outcomes. No prior systematic review has been performed on this topic to my knowledge. The introduction, methods, and discussion are clear and concise. The inclusion of grey literature is appropriate for this research given the relative lack of published data as long as these studies are clearly identified in the manuscript if included. The inclusion of randomized and nonrandomized data is also appropriate for this research question.
Thank you for taking the time to review our systematic review protocol. We appreciate the opportunity to improve our manuscript and methods. Please state any competing interests: None declared 1. Thank you for asking to review the protocol for the planned systematic review. The protocol and plan adheres to standard guidelines and methodology for syst review and MA. I suggest clarifying the method by which RCTs vs Non-RCTs will be assessed.
Thank you for this suggestion. Study quality for RCTs will be assessed using the Cochrane Collaboration tool, which we will use to report a summary assessment for the risk of bias in each study. Non-RCTs (observational studies) will be assessed using the Newcastle Ottawa scale and all scores will be reported in the final manuscript. For clarification, we have inserted the word "randomized" into this section on study quality, and hope this is what you were referring to. We are happy to modify further if you deem necessary.
2. In addition the heterogeneity level may be dictated by the point estimate as well as the I2 test
We intend to report the point estimate of heterogeneity and its associated 95% confidence interval in our systematic review. However, this was not clear in our manuscript. We have reworded our paragraph addressing heterogeneity as below. "Heterogeneity between studies will be assessed using the I2 statistic, and will be reported as a point estimate with 95% confidence intervals. We will interpret this statistic using suggested thresholds for low (25-49%), moderate (50-74%), and high (≥75%) 
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No further comments
